1-3 of 3
Yajin Ni
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ALLO-715, an Allogeneic BCMA CAR T Therapy Possessing an Off-Switch for the Treatment of Multiple Myeloma

Cesar Sommer, PhD, Bijan Boldajipour, PhD, Julien Valton, PhD, Roman Galetto, PhD, Trevor Bentley, Janette Sutton, Yajin Ni, PhD, Mark Leonard, PhD, Thomas Van Blarcom, PhD, Julianne Smith, PhD, Javier Chaparro-Riggers, PhD, Barbra Sasu, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 591.
https://doi.org/10.1182/blood-2018-99-119227
Published: 2018
Journal Articles

CD86 and CD54 Co-Expression on VSV-G Pseudotyped HIV-1 Based Vectors Improves Transduction and Activation of Human Primary CD4+ T Lymphocytes.

Brian Paszkiet, MA, Andrew Worden, Yajin Ni, PhD, Saran Bao, BA, Franck Lemiale, PhD, PharmD, Boro Dropulic, PhD, Laurent Humeau, PhD
Journal: Blood
Blood (2004) 104 (11): 1754.
https://doi.org/10.1182/blood.V104.11.1754.1754
Published: 2004
Journal Articles

ABC transporter inhibitors that are substrates enhance lentiviral vector transduction into primitive hematopoietic progenitor cells

Brian M. Davis, Laurent Humeau, Vladimir Slepushkin, Gwendolyn Binder, Lauren Korshalla, Yajin Ni, E. Oluwakemi Ogunjimi, Lan-Fei Chang, Xiaobin Lu, Boro Dropulic
Journal: Blood
Blood (2004) 104 (2): 364–373.
https://doi.org/10.1182/blood-2003-07-2363
Published: 2004